49,289
edits
Difference between revisions of "Hereditary leiomyomatosis and renal cell carcinoma syndrome"
Jump to navigation
Jump to search
Hereditary leiomyomatosis and renal cell carcinoma syndrome (view source)
Revision as of 13:53, 25 August 2014
, 13:53, 25 August 2014no edit summary
| Line 1: | Line 1: | ||
'''Hereditary leiomyomatosis and renal cell carcinoma''' (abbreviated '''HLRCC'''), also '''hereditary leiomyomatosis and renal cell cancer''', is an uncommon syndrome caused by fumarate hydratase (FH) gene mutations.<ref name=omim136850>{{OMIM|136850}}</ref> | '''Hereditary leiomyomatosis and renal cell carcinoma''' (abbreviated '''HLRCC'''), also '''hereditary leiomyomatosis and renal cell cancer''', is an uncommon syndrome caused by fumarate hydratase (FH) gene mutations.<ref name=omim136850>{{OMIM|136850}}</ref> | ||
==General== | |||
HLRCC is classically described as:<ref name=Ref_WMSP290>{{Ref WMSP|290}}</ref> | |||
* [[Papillary renal cell carcinoma]] type 2. | * [[Papillary renal cell carcinoma]] type 2. | ||
* Benign [[leiomyoma]]s skin/[[uterine leiomyoma|uterus]]. | * Benign [[leiomyoma]]s skin/[[uterine leiomyoma|uterus]]. | ||